Suppr超能文献

相似文献

1
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Mult Scler. 2014 Feb;20(2):202-13. doi: 10.1177/1352458513493034. Epub 2013 Jun 26.
2
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
J Neurol Sci. 2009 Jul 15;282(1-2):106-11. doi: 10.1016/j.jns.2008.11.018. Epub 2008 Dec 19.
3
6
Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.
7
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
J Neurol Sci. 2009 Jul 15;282(1-2):55-60. doi: 10.1016/j.jns.2009.02.322. Epub 2009 Mar 16.
8
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
Neuroimage. 2014 Feb 1;86:257-64. doi: 10.1016/j.neuroimage.2013.09.059. Epub 2013 Oct 4.
9
Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Brain. 2024 Jan 4;147(1):135-146. doi: 10.1093/brain/awad288.
10
Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis.
J Neuroradiol. 2017 Mar;44(2):158-164. doi: 10.1016/j.neurad.2016.10.001. Epub 2016 Nov 16.

引用本文的文献

1
Women in the field of multiple sclerosis: How they contributed to paradigm shifts.
Front Mol Neurosci. 2023 Feb 3;16:1087745. doi: 10.3389/fnmol.2023.1087745. eCollection 2023.
2
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.
Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018.
3
Phase IV study of retention on fingolimod injectable multiple sclerosis therapies: a randomized clinical trial.
Ther Adv Neurol Disord. 2018 May 20;11:1756286418774338. doi: 10.1177/1756286418774338. eCollection 2018.
4
Structural abnormalities and altered regional brain activity in multiple sclerosis with simple spinal cord involvement.
Br J Radiol. 2018 Feb;91(1083):20150777. doi: 10.1259/bjr.20150777. Epub 2018 Jan 31.
5
Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study.
Neuroimage Clin. 2017 Nov 5;17:444-451. doi: 10.1016/j.nicl.2017.11.002. eCollection 2018.
6
How changes in brain activity and connectivity are associated with motor performance in people with MS.
Neuroimage Clin. 2017 Sep 28;17:153-162. doi: 10.1016/j.nicl.2017.09.019. eCollection 2018.
7
8
Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations.
Mult Scler J Exp Transl Clin. 2015 Jun 10;1:2055217315589775. doi: 10.1177/2055217315589775. eCollection 2015 Jan-Dec.
9
MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.
Ther Adv Neurol Disord. 2017 Jun;10(6):247-261. doi: 10.1177/1756285617708911. Epub 2017 May 12.
10
Outcome Measures in Clinical Trials for Multiple Sclerosis.
CNS Drugs. 2017 Mar;31(3):217-236. doi: 10.1007/s40263-017-0412-5.

本文引用的文献

1
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects.
Lancet Neurol. 2012 May;11(5):467-76. doi: 10.1016/S1474-4422(12)70059-5.
2
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
Mult Scler. 2012 Oct;18(10):1466-71. doi: 10.1177/1352458512442438. Epub 2012 Apr 4.
3
Longitudinal gray matter changes in multiple sclerosis--differential scanner and overall disease-related effects.
Hum Brain Mapp. 2012 May;33(5):1225-45. doi: 10.1002/hbm.21279. Epub 2011 Apr 29.
4
The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.
J Neuroimaging. 2012 Apr;22(2):122-8. doi: 10.1111/j.1552-6569.2011.00589.x. Epub 2011 Mar 29.
5
Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue.
AJNR Am J Neuroradiol. 2011 May;32(5):874-9. doi: 10.3174/ajnr.A2412. Epub 2011 Mar 10.
6
Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.
Mult Scler. 2011 Jun;17(6):681-9. doi: 10.1177/1352458510391342. Epub 2010 Dec 21.
7
Cervical cord and brain grey matter atrophy independently associate with long-term MS disability.
J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):471-2. doi: 10.1136/jnnp.2010.205021. Epub 2010 Aug 14.
8
Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.
Mult Scler. 2010 Oct;16(10):1220-8. doi: 10.1177/1352458510376405. Epub 2010 Jul 29.
9
The multiple sclerosis functional composite: a clinically meaningful measure of disability.
Neurology. 2010 Apr 27;74 Suppl 3:S8-15. doi: 10.1212/WNL.0b013e3181dbb571.
10
Relationship of cortical atrophy to fatigue in patients with multiple sclerosis.
Arch Neurol. 2010 Apr;67(4):447-53. doi: 10.1001/archneurol.2010.48.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验